COMPARATIVE EVALUATION OF CLINIC-IMMUNOLOGICAL DATA IN PATIENTS WITH TRAUMATIC BRAIN INJURY OF DIFFERENT SEVERITY LEVEL IN ACUTE PERIOD.


  • A.O. Norka Pavlov First Saint Petersburg State Medical University, Russia
  • S.V. Vorobyev Saint Petersburg State Pediatric Medical University, Russia
  • R.N. Kuznetsova Saint Petersburg Pauster Institute, Russia
  • S.V. Kudryavtsev Federal State Budgetary Scientific Institution «Institute of Experimental Medicine», Russia
  • S.N. Kovalenko S.M. Kirov Military Medical Academy, Russia
DOI: https://doi.org/10.29256/v.02.02.2018.escbm39
Keywords: Traumatic brain injury, immunology, T helper subsets

Abstract

COMPARATIVE EVALUATION OF CLINIC-IMMUNOLOGICAL DATA IN PATIENTS WITH TRAUMATIC BRAIN INJURY OF DIFFERENT SEVERITY LEVEL IN ACUTE PERIOD.

References

1. Cesar Reis, Yuechun Wang , Onat Akyol, What’s New in Traumatic Brain Injury: Update on Tracking, Monitoring and Treatment, Int. J. Mol. Sci. 2015, 16, 11903-11965; doi:10.3390/ijms160611903.

2. Damir Nizamutdinov, Lee Shapiro, Overview of Traumatic Brain Injury: An Immunological Context, Brain Sciences, 2017, 7, 11. doi: 10.3390/brainsci7010011.

3. Role of regulatory T cell in clinical outcome of traumatic brain injury, Chin Med J (Engl). 2015 Apr 20;128(8):1072-8. doi: 10.4103/0366-6999.155094.

4. Cell-Based therapy for traumatic brain injury, Br J Anaesth. 2015 Aug; 115(2): 203–212.

5. Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift, Neuron. 2017 Sep 13;95(6):1246-1265. doi: 10.1016/j.neuron.2017.07.010.
Published
2018-11-15
How to Cite
Norka, A., Vorobyev, S., Kuznetsova, R., Kudryavtsev, S., & Kovalenko, S. (2018). COMPARATIVE EVALUATION OF CLINIC-IMMUNOLOGICAL DATA IN PATIENTS WITH TRAUMATIC BRAIN INJURY OF DIFFERENT SEVERITY LEVEL IN ACUTE PERIOD. Biological Markers in Fundamental and Clinical Medicine (scientific Journal), 2(2), 48-49. https://doi.org/10.29256/v.02.02.2018.escbm39
Issue
Vol 2 No 2 (2018): BIOLOGICAL MARKER
Section
Selected abstracts
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.